MB04
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MB04, covering 2025-03-24 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders [Phase 1]